Keiju Aokage

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

Hisashi Saji, Morihito Okada, Masahiro Tsuboi et al. · The Lancet · 2022 · 1.5K citations

Surgical Oncology, Medicine, Cancer Management +10

The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies

Shogo Kumagai, Yosuke Togashi, Takahiro Kamada et al. · Nature Immunology · 2020 · 785 citations

Cancer Immunosurveillance, Autoimmune Disease, T-regulatory Cell +12

Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments

Shogo Kumagai, Shohei Koyama, Kota Itahashi et al. · Cancer Cell · 2022 · 752 citations

Cancer Immunosurveillance, Pd-1 Expression, Medicine +11

Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial

Kenji Suzuki, Hisashi Saji, Keiju Aokage et al. · Journal of Thoracic and Cardiovascular Surgery · 2019 · 488 citations · Full text

Interventional Pulmonology, Pulmonary Care, Outcomes Research +8

Predominant infiltration of macrophages and CD8⁺ T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer

Osamu Kawai, Genichiro Ishii, Kaoru Kubota et al. · Cancer · 2008 · 382 citations · Full text